NCT06110078View on ClinicalTrials.gov

Carbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda Consumption

EARLY_PHASE1Enrolling by invitationINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

January 18, 2024

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions

Obesity

Interventions

DRUG

Acetazolamide

Oral rinse with acetazolamide (not taken orally)

Trial Locations (1)

85004

College of Medicine Phoenix U of Arizona, Phoenix

All Listed Sponsors

lead

University of Arizona

OTHER